التفاصيل البيبلوغرافية
| العنوان: |
"Vaccine Compositions And Methods For Treating Hsv" in Patent Application Approval Process (USPTO 20240156951). |
| المصدر: |
Vaccine Weekly; 6/7/2024, p98-98, 1p |
| مصطلحات موضوعية: |
PATENT applications, HUMAN herpesvirus 2, AMINO acid sequence, AIDS, HUMAN herpesvirus 1 |
| مستخلص: |
A patent application has been filed for a vaccine composition that aims to prevent and treat herpes simplex virus (HSV) infections. The vaccine includes mRNAs that encode HSV structural proteins or immunogenic fragments, which are designed to elicit an immune response to prevent infection and reactivation. The vaccine can be administered through different routes, such as injection or topical application, and may include a carrier or adjuvant. Current therapies for HSV can control symptoms but cannot prevent periodic reactivation of the virus. This vaccine composition offers a potential new approach to addressing HSV infections. [Extracted from the article] |
|
Copyright of Vaccine Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
